Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_1
3
100%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Not yet recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 13 (100.0%)

Trials by Status

unknown133%
not_yet_recruiting267%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_1

Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma

NCT06384248
not_yet_recruitingphase_1

Phase II Clinical Study of LTC004 in Patients With mCRC

NCT06384235
unknownphase_1

Study of LTC004 in Subjects With Advanced Malignant Tumors

NCT05666635

Clinical Trials (3)

Showing 3 of 3 trials
NCT06384248Phase 1

Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma

Not Yet Recruiting
NCT06384235Phase 1

Phase II Clinical Study of LTC004 in Patients With mCRC

Not Yet Recruiting
NCT05666635Phase 1

Study of LTC004 in Subjects With Advanced Malignant Tumors

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3